Optimal number of chemotherapy courses in advanced nonseminomatous testicular carcinoma.

Kennedy, B J; Torkelson, J; Fraley, E E

Kennedy, B J; Torkelson, J; Fraley, E E.

Affiliation

Kennedy BJ; Department of Medicine, University of Minnesota Medical School, University Hospital, Minneapolis 55455, USA.

Am J Clin Oncol ; 18(6): 463-8, 1995 Dec.

Article in En | MEDLINE | ID: mdl-8526185

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Germinoma/drug therapy; Testicular Neoplasms/drug therapy; Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Agents/administration & dosage; Antineoplastic Agents, Phytogenic/administration & dosage; Bleomycin/administration & dosage; Cisplatin/administration & dosage; Follow-Up Studies; Germinoma/pathology; Humans; Male; Neoplasm Recurrence, Local/drug therapy; Neoplasm Staging; Remission Induction; Testicular Neoplasms/pathology; Treatment Failure; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Germinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Am J Clin Oncol Year: 1995 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links